A Key MicroRNA That Controls Eye Pressure

About the Research Project
Program
Award Type
Standard
Award Amount
$99,546
Active Dates
July 01, 2018 - June 30, 2020
Grant ID
G2018112
Goals
The most effective therapy for glaucoma is reducing eye pressure, but it is not understood how the pressure in the eye is regulated. MicroRNAs (miRNAs) are very small genetic sequences that can regulate the expression of many genes. In fact, a single miRNA is so powerful that it can modulate several genes. The aim of this project is to understand the role of a very important miRNA in regulating intraocular pressure (IOP). This may be a very effective new way to treat elevated eye pressure in glaucoma.
Summary
Primary open angle glaucoma (POAG) is an irreversible eye blinding disease. Schlemm’s canal (SC) inner wall and juxtacanalicular (JCT) tissue are thought to be the sites of major aqueous outflow resistance, which is responsible for elevated eye pressure characteristic of many cases of POAG. Therefore it is important to understand how SC cells regulate eye pressure. Our early work suggest that miRNAs participate eye pressure regulation, it this project we will use molecular biology and pharmacology techniques to understand the mechanism of such regulations. This work might pave the way to the discovery of a new pathway that controls IOP.
Related Grants
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University